--- a
+++ b/clusters/9knumclustersv2/clust_1109.txt
@@ -0,0 +1,37 @@
+History of grade - immediate hypersensitivity reaction to paclitaxel
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+Is unable to receive any of the agents used in this study due a history of severe immediate hypersensitivity reaction (e.g. hypersensitivity to dimethyl sulfoxide (DMSO))
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to cyclophosphamide, fludarabine, or aldesleukin.
+History of severe immediate hypersensitivity reaction to cyclophosphamide, fludarabine, or aldesleukin
+History of severe immediate hypersensitivity reaction to cyclophosphamide or fludarabine
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to cyclophosphamide, aldesleukin, or fludarabine
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to cyclophosphamide, fludarabine or aldesleukin
+History of severe immediate hypersensitivity reaction to cyclophosphamide or fludarabine
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to cyclophosphamide, fludarabine, or aldesleukin
+Patients who are (MVF-HER-[-] and MVF-HER- [-]) immediate hypersensitivity skin test positive
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to cyclophosphamide or fludarabine phosphate (fludarabine)
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to any of the agents used in this study
+History of severe immediate hypersensitivity reaction to cyclophosphamide or fludarabine (fludarabine phosphate)
+History of severe immediate hypersensitivity reaction to cyclophosphamide or fludarabine
+History of severe, immediate hypersensitivity reaction attributed to aminoglycosides